Implementation of SARS-CoV-2 Monoclonal Antibody Infusion Sites at Three Medical Centers in the United States Strengths and Challenges Assessment to

The authors of this article conducted a descriptive analysis from three sites at medical centers in the U.S. supported by the National Disaster Medical System to examine the monoclonal antibody infusion site process during the COVID-19 pandemic. The authors discuss several successes and challenges in implementing these sites.
Rate: Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.